Skip to content

Clinical trials

Terminated Phase 2/3 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2/3 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20071
20081
20113
20131
20142
20182
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute2
Dartmouth-Hitchcock Medical Center1
European Organisation for Research and Treatment of Cancer - EORTC1
Immutep S.A.S.1
Koning Corporation1
M.D. Anderson Cancer Center1
Melissa Voigt Hansen1
Merrimack Pharmaceuticals1
Ottawa Heart Institute Research Corporation1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms14
Colorectal Neoplasms2
Lung Neoplasms2
Anxiety Disorders1
Head and Neck Neoplasms1
Heart Failure1
Heart Failure, Diastolic1
Melanoma1
Musculoskeletal Diseases1
Neoplasm Metastasis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.